IMPACT BIOMEDICAL INC.IBOEarnings & Financial Report
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), founded at the National Institutes of Health (NIH) in 2000, is located in Bethesda, Maryland. It is one of 27 institutes and centers that are part of NIH, an agency of the U.S. Department of Health and Human Services (HHS).
Revenue
$7.0K
Gross Profit
$-4.0K
Operating Profit
$-1.2M
Net Profit
$-14.3M
Gross Margin
-57.1%
Operating Margin
-16471.4%
Net Margin
-204942.9%
YoY Growth
N/A
EPS
$-1.18
IMPACT BIOMEDICAL INC. Q2 FY2025 Financial Summary
IMPACT BIOMEDICAL INC. reported revenue of $7.0K for Q2 FY2025, with a net profit of $-14.3M (down 1513.7% YoY) (-204942.9% margin). Cost of goods sold was $11.0K, operating expenses totaled $1.1M.
Key Financial Metrics
| Total Revenue | $7.0K |
|---|---|
| Net Profit | $-14.3M |
| Gross Margin | -57.1% |
| Operating Margin | -16471.4% |
| Report Period | Q2 FY2025 |
IMPACT BIOMEDICAL INC. Quarterly Revenue & Net Profit History
IMPACT BIOMEDICAL INC. results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $18.0K | — | $-1.5M | -8166.7% |
| Q2 FY2025 | $7.0K | — | $-14.3M | -204942.9% |
Income Statement
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Revenue | $7000 | $18000 |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Assets | $19.1M | $18.2M |
| Liabilities | $26.4M | $27.1M |
| Equity | $-10.3M | $-11.8M |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-694000 | $-613000 |